SCHEMBL8666607

SCHEMBL8666607

[CH](Cc1ccc2[nH]ncc2c1)c1ccc2[nH]ncc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.51
NOS1 P29475 4/20 0.46
MAPT P10636 2/20 0.46
ROCK2 O75116 2/20 0.46
METAP2 P50579 1/20 0.46
CSNK2A1 P68400 1/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
ROCK1 Q13464 1/20 0.46
HIF1A Q16665 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MAOB P27338 5/20 0.45
NEK2 P51955 1/20 0.44
CLK1 P49759 2/20 0.42
GSK3B P49841 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8669601 0.84 NOS1 (0.46) MAPK1NOS1MAPTMETAP2KDM4E
SCHEMBL1605539 0.80 MAPK1 (0.57) MAPK1NOS1MAPTROCK2METAP2
SCHEMBL29569257 0.78 NOS1 (0.53) MAPK1NOS1MAPTROCK2METAP2
SCHEMBL182465 0.78 NOS1 (0.53) MAPK1NOS1MAPTROCK2METAP2
SCHEMBL8666610 0.77 NOS1 (0.57) MAPK1NOS1MAPTROCK2METAP2
SCHEMBL8713967 0.75 FGFR1 (0.51) NOS1MAPTMETAP2KDM4EMEN1
SCHEMBL15069783 0.74 MAPK1 (0.55) MAPK1NOS1MAPTROCK2METAP2
SCHEMBL764032 0.74 CDC7 (0.55) MAPK1NOS1MAPTROCK2METAP2
SCHEMBL12833351 0.74 NOS1 (0.53) MAPK1NOS1MAPTROCK2METAP2
SCHEMBL6599321 0.74 ROCK2 (0.53) MAPK1NOS1MAPTROCK2METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed
EP-0686151-A1 SUBSTITUTED CYCLIC CARBONYLS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-12-13 EP disclosed